Free Trial

Medifast (MED) Competitors

Medifast logo
$16.92 -0.22 (-1.28%)
(As of 12/20/2024 05:40 PM ET)

MED vs. HLF, USNA, NUS, NATR, VERU, EL, IPAR, PBH, FARM, and JVA

Should you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Farmer Bros. (FARM), and Coffee (JVA).

Medifast vs.

Medifast (NYSE:MED) and Herbalife (NYSE:HLF) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Medifast has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Herbalife has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Herbalife has higher revenue and earnings than Medifast. Herbalife is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifast$674.48M0.27$99.42M$0.6625.64
Herbalife$5.00B0.13$142.20M$0.857.62

In the previous week, Herbalife had 1 more articles in the media than Medifast. MarketBeat recorded 4 mentions for Herbalife and 3 mentions for Medifast. Herbalife's average media sentiment score of 0.37 beat Medifast's score of 0.02 indicating that Herbalife is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medifast
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Herbalife
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Medifast currently has a consensus price target of $17.00, suggesting a potential upside of 0.47%. Herbalife has a consensus price target of $9.90, suggesting a potential upside of 52.78%. Given Herbalife's stronger consensus rating and higher probable upside, analysts clearly believe Herbalife is more favorable than Medifast.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Herbalife
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 39.0%. Herbalife pays an annual dividend of $1.20 per share and has a dividend yield of 18.5%. Medifast pays out 1,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Herbalife pays out 141.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Herbalife received 332 more outperform votes than Medifast when rated by MarketBeat users. Likewise, 67.26% of users gave Herbalife an outperform vote while only 63.62% of users gave Medifast an outperform vote.

CompanyUnderperformOutperform
MedifastOutperform Votes
383
63.62%
Underperform Votes
219
36.38%
HerbalifeOutperform Votes
715
67.26%
Underperform Votes
348
32.74%

95.5% of Medifast shares are owned by institutional investors. 2.5% of Medifast shares are owned by insiders. Comparatively, 0.9% of Herbalife shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Herbalife has a net margin of 1.73% compared to Medifast's net margin of 1.09%. Medifast's return on equity of 15.98% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
Medifast1.09% 15.98% 11.01%
Herbalife 1.73%-18.66%7.12%

Summary

Herbalife beats Medifast on 12 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MED vs. The Competition

MetricMedifastfood preparations & kindred products IndustryStaples SectorNYSE Exchange
Market Cap$185.07M$3.12B$14.03B$19.19B
Dividend YieldN/A3.12%2.76%3.58%
P/E Ratio25.648.8621.9641.22
Price / Sales0.270.982.6117.58
Price / Cash1.7712.2621.1421.28
Price / Book0.911.825.855.32
Net Income$99.42M$136.11M$572.90M$989.67M
7 Day Performance-11.69%-6.44%-1.80%-3.45%
1 Month Performance-7.54%-5.52%-3.00%-3.73%
1 Year Performance-75.21%42.72%2.85%12.06%

Medifast Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MED
Medifast
1.5391 of 5 stars
$16.92
-1.3%
$17.00
+0.5%
-74.7%$185.07M$674.48M25.64870
HLF
Herbalife
4.6776 of 5 stars
$7.23
-3.3%
$9.90
+36.9%
-56.6%$728.73M$5.00B8.669,200
USNA
USANA Health Sciences
2.7805 of 5 stars
$36.57
-0.2%
$35.00
-4.3%
-35.6%$697.02M$921.01M12.951,800Analyst Upgrade
News Coverage
NUS
Nu Skin Enterprises
3.55 of 5 stars
$7.34
-2.0%
$8.88
+20.9%
-65.8%$364.88M$1.78B-3.593,700Analyst Forecast
Analyst Revision
Gap Down
NATR
Nature's Sunshine Products
3.7941 of 5 stars
$15.64
+0.2%
$19.00
+21.5%
-14.4%$288.97M$445.10M17.55814
VERU
Veru
1.9745 of 5 stars
$0.74
+2.4%
$4.00
+440.5%
-3.5%$108.32M$14.09M-1.51189Earnings Report
Analyst Forecast
EL
Estée Lauder Companies
4.8829 of 5 stars
$79.50
-0.7%
$98.57
+24.0%
-48.2%$28.54B$15.61B142.9362,000Positive News
IPAR
Inter Parfums
4.5438 of 5 stars
$135.88
-0.2%
$159.75
+17.6%
-8.2%$4.35B$1.42B29.36530Analyst Forecast
PBH
Prestige Consumer Healthcare
3.7947 of 5 stars
$82.65
+0.4%
$85.25
+3.1%
+29.7%$4.08B$1.11B20.02540Analyst Upgrade
Positive News
FARM
Farmer Bros.
4.1077 of 5 stars
$1.87
-1.3%
$5.25
+180.1%
-41.3%$39.87M$344.27M-5.281,003Positive News
JVA
Coffee
1.2054 of 5 stars
$4.17
-2.8%
N/A+306.7%$23.81M$76.11M21.4580Gap Down

Related Companies and Tools


This page (NYSE:MED) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners